Buprenorphine

The Substance Abuse and Mental Health Services Administration issued a final rule that permanently allows patients to be prescribed buprenorphine via telehealth, the U.S. Department of Health and Human Services announced in a press release.

Use of the JADA system, an intrauterine vacuum-induced hemorrhage control device, led to rapid and effective bleeding control for vaginal and cesarean births, according to real-world study results published in Obstetrics & Gynecology.

Infants exposed in utero to buprenorphine had lower risk for malformations associated with opioid exposure compared with methadone-exposed infants, according to cohort study results published in JAMA Internal Medicine.

Patients with opioid use disorder, or OUD, who were treated with buprenorphine during an ED visit had greater odds of continued treatment engagement 30 days later, a study in JAMA Network Open showed.

Patients prescribed buprenorphine at 24 mg for opioid use disorder were more likely to remain in treatment compared with those prescribed a 16 mg dose, a study in JAMA Network Open showed.

Although mean daily out-of-pocket costs for buprenorphine — a medication for opioid use disorder — fell from 2015 to 2020 in the United States, cost remains a barrier for many people, according to findings published in JAMA Pediatrics.

Only one-quarter of residential addiction treatment centers caring for adolescents in the United States offer buprenorphine to patients with opioid use disorder, according to findings published Tuesday in JAMA.

MIAMI BEACH, Fla. — Treatment with subcutaneous buprenorphine on a weekly or monthly basis eased cravings and withdrawals in those with opioid use disorder, per data from the American Society of Clinical Psychopharmacology annual meeting.

About 58% of pharmacies reported availability of buprenorphine for opioid use disorder at the time of patients’ requests, according to researchers.

The FDA announced that it has approved Brixadi, an extended-release subcutaneous injection for the treatment of moderate to severe opioid use disorder.